Author

Lisbet Ambrosius Christensen 1

1 Aarhus University Hospital,Aarhus ,Denmark

ADALIMUMAB AND INFLIXIMAB CLEARANCE IN NEONATES (ERA STUDY)

Mette Julsgaard, Lisbet Ambrosius Christensen, Peter R. Gibson, Richard Blair Gearry, Jan Fallingborg, jens kjeldsen, Signe Wildt, Lise Svenningsen, William Connell, Christian Lodberg Hvas, Miles P. Sparrow, Alissa Walsh, Susan J. Connor, Graham Radford-Smith, Ian Lawrance, Jane Andrews, Katie Ellard, Ourania Rosella, Ann

IS FECAL CALPROTECTIN THE BETTER TOOL TO MONITOR DISEASE ACTIVITY IN PREGNANT IBD PATIENTS?

Mette Julsgaard, Lisbet Ambrosius Christensen, Christian Lodberg Hvas, Jan Fallingborg, Lise Svenningsen, jens kjeldsen, Miles P. Sparrow, Signe Wildt, Sally J. Bell

RANDOMISED CLINICAL TRIAL: CASEIN GLYCOMACROPEPTIDE FOR ACTIVE DISTAL ULCERATIVE COLITIS – A PILOT STUDY

Pernille Glahn Wernlund, Christian Lodberg Hvas, Anders Kirch Dige, Mia Bendix, Lisbet Ambrosius Christensen, Jens Frederik Dahlerup, Jørgen Agnholt

TIME SINCE LAST DRUG EXPOSURE IN PREGNANCY DETERMINES ADALIMUMAB AND INFLIXIMAB LEVELS IN NEONATES (ERA STUDY)

Mette Julsgaard, Lisbet Ambrosius Christensen, Peter R. Gibson, Jan Fallingborg, Richard Blair Gearry, Miles P. Sparrow, Jane Andrews, Susan J. Connor, Ian Lawrence, Signe Wildt, Gregory Moore, Lise Svenningsen

Item 1 - 4 / 10
1